Water-soluble acetaminophen analogs
US-2019092795-A1 · Mar 28, 2019 · US
Water-soluble acetaminophen analogs
US11021498B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-11021498-B2 |
| Application number | US-201916565173-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 9, 2019 |
| Priority date | May 20, 2008 |
| Publication date | Jun 1, 2021 |
| Grant date | Jun 1, 2021 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides water-soluble acetaminophen prodrugs and formulations which may be suitable for parenteral administration. Methods of treating a disease or condition responsive to acetaminophen (such as fever and/or pain) using the acetaminophen prodrugs, as well as kits, unit dosages, and combinations with additional pharmaceutical agent(s) are also provided.
First claim
Opening claim text (preview).
The invention claimed is: 1. A compound of formula (I): or a pharmaceutically acceptable salt thereof or solvate of the foregoing.
Assignees
Inventors
Classifications
- C07F9/091Primary
with hydroxyalkyl compounds with further substituents on alkyl · CPC title
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title
Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca · CPC title
Drugs for disorders of the nervous system · CPC title
Phosphorus acids or esters thereof not having P—C bonds, e.g. fosfosal, dichlorvos, malathion {or mevinphos} · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US11021498B2 cover?
- The present invention provides water-soluble acetaminophen prodrugs and formulations which may be suitable for parenteral administration. Methods of treating a disease or condition responsive to acetaminophen (such as fever and/or pain) using the acetaminophen prodrugs, as well as kits, unit dosages, and combinations with additional pharmaceutical agent(s) are also provided.
- Who is the assignee on this patent?
- Acorda Therapeutics Inc
- What technology area does this patent fall under?
- Primary CPC classification C07F9/091. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).